BridgeMD
New treatment option for Acne Vulgaris
Official title Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study
ClinicalTrials.gov ID: NCT07056673
What this study is testing
- What it's testing
- Acne vulgaris is a common, chronic inflammatory skin disease with complex pathogenesis and limited therapeutic options, especially for moderate-to-severe cases. Standard treatments-including topical and oral agents-are often constrained by side effects, antimicrobial resistance, and treatment resistance.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Aged 18-40 years;
- Clinically diagnosed with acne vulgaris, with moderate to severe disease (Pillsbury grade III or IV, lesion count ≥50);
- Will agree to use effective contraception during the treatment period;
- Will sign a written informed consent form.
You likely can't join if
- Pregnant or breastfeeding women;
- Known allergy to any active component of CAP;
- Use of systemic antibiotics within 4 weeks prior to enrollment;
- Presence of dyslipidemia or other severe systemic diseases;
- Participation in other clinical trials within the past 3 months or currently enrolled in another clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Luoyang, Henan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Luoyang, Henan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.